Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

COCH Envoy Medical, Inc. Class A Common Stock
$0.68 -9.75% -0.07
Notify me if price changes either direction
Interactive Brokers Logotype

Buy COCH stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 50.2M
Enterprise value 47.4M
Trailing PE -0.43570469798658
Forward PE -0.68694735
PEG Ratio 0.080605369127517
Enterprise to EBITDA -2.174
Enterprise to revenue 196.484
Price to book MRQ -1.8836891004116
Price to sales TTM 208.18512

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 241.0K
EBITDA -21778000
Diluted EPS TTM -1.23
Total Cash (MRQ) 3.7M
Current ratio (MRQ) 0.543
Operating Cash Flow (TTM) -18201000

COCH trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent COCH News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.